Australia Markets close in 4 hrs 11 mins

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.48+0.08 (+0.95%)
At close: 09:30AM EST
Full screen
Trade prices are not sourced from all markets
Previous close8.40
Open8.54
Bid7.95 x 1200
Ask25.00 x 1400
Day's range8.33 - 8.89
52-week range8.00 - 21.55
Volume256
Avg. volume2,412
Market cap292.192M
Beta (5Y monthly)2.28
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est26.56
  • Business Wire

    NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference

    PARIS & CAMBRIDGE, Mass., November 17, 2021--Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chief executive officer, will participate in a virtual fireside chat at the 4th annual Evercore ISI HealthCONx Conference on Thursday, December 2, 2021, at 1:0

  • Business Wire

    NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkpoint Inhibitor Combination

    PARIS & CAMBRIDGE, Mass., November 09, 2021--Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the "Company"), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced new preclinical immunotherapy data for novel, potentially solid tumor- and therapeutic combination-agnostic radioenhancer NBTXR3 that will be presented at the 2021 Annual Meeting of the Society for the Immunotherapy of Can

  • Business Wire

    Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

    PARIS, November 08, 2021--Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX):